Bit Bio Ltd

Bit Bio Limited develops synthetic biology solutions for human cell research and therapy. The Company provides iPSC-derived cell products, disease models, and cell programming technologies for biomedical applications. Bit Bio Ltd serves biomedical researchers and drug discovery organizations in Europe, the United Kingdom, and the United States.